NM_021098.3:c.498C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_021098.3(CACNA1H):c.498C>T(p.Tyr166Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00254 in 1,604,376 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0048 ( 10 hom., cov: 33)
Exomes 𝑓: 0.0023 ( 40 hom. )
Consequence
CACNA1H
NM_021098.3 synonymous
NM_021098.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.66
Publications
3 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 16-1195518-C-T is Benign according to our data. Variant chr16-1195518-C-T is described in ClinVar as [Benign]. Clinvar id is 460135.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.66 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00479 (729/152234) while in subpopulation EAS AF = 0.0309 (160/5172). AF 95% confidence interval is 0.027. There are 10 homozygotes in GnomAd4. There are 508 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 729 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.498C>T | p.Tyr166Tyr | synonymous_variant | Exon 4 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
CACNA1H | ENST00000569107.6 | c.498C>T | p.Tyr166Tyr | synonymous_variant | Exon 4 of 34 | 1 | ENSP00000454990.2 | |||
CACNA1H | ENST00000711493.1 | c.498C>T | p.Tyr166Tyr | synonymous_variant | Exon 4 of 34 | ENSP00000518778.1 | ||||
CACNA1H | ENST00000565831.7 | c.498C>T | p.Tyr166Tyr | synonymous_variant | Exon 4 of 34 | 1 | ENSP00000455840.1 | |||
CACNA1H | ENST00000711450.1 | c.498C>T | p.Tyr166Tyr | synonymous_variant | Exon 4 of 35 | ENSP00000518762.1 | ||||
CACNA1H | ENST00000564231.6 | c.498C>T | p.Tyr166Tyr | synonymous_variant | Exon 4 of 35 | 1 | ENSP00000457555.2 | |||
CACNA1H | ENST00000638323.1 | c.459C>T | p.Tyr153Tyr | synonymous_variant | Exon 4 of 35 | 5 | ENSP00000492267.1 | |||
CACNA1H | ENST00000562079.6 | c.498C>T | p.Tyr166Tyr | synonymous_variant | Exon 4 of 34 | 1 | ENSP00000454581.2 | |||
CACNA1H | ENST00000711438.1 | c.459C>T | p.Tyr153Tyr | synonymous_variant | Exon 4 of 34 | ENSP00000518754.1 | ||||
CACNA1H | ENST00000711482.1 | c.498C>T | p.Tyr166Tyr | synonymous_variant | Exon 4 of 36 | ENSP00000518771.1 | ||||
CACNA1H | ENST00000711485.1 | c.498C>T | p.Tyr166Tyr | synonymous_variant | Exon 4 of 35 | ENSP00000518774.1 | ||||
CACNA1H | ENST00000711455.1 | c.498C>T | p.Tyr166Tyr | synonymous_variant | Exon 4 of 36 | ENSP00000518768.1 | ||||
CACNA1H | ENST00000711483.1 | c.498C>T | p.Tyr166Tyr | synonymous_variant | Exon 4 of 35 | ENSP00000518772.1 | ||||
CACNA1H | ENST00000711456.1 | c.498C>T | p.Tyr166Tyr | synonymous_variant | Exon 4 of 34 | ENSP00000518769.1 | ||||
CACNA1H | ENST00000621827.2 | n.498C>T | non_coding_transcript_exon_variant | Exon 4 of 37 | 6 | ENSP00000518766.1 | ||||
CACNA1H | ENST00000637236.3 | n.498C>T | non_coding_transcript_exon_variant | Exon 4 of 34 | 5 | ENSP00000492650.2 | ||||
CACNA1H | ENST00000639478.1 | n.498C>T | non_coding_transcript_exon_variant | Exon 4 of 35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.498C>T | non_coding_transcript_exon_variant | Exon 4 of 35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000711442.1 | n.498C>T | non_coding_transcript_exon_variant | Exon 4 of 34 | ENSP00000518758.1 | |||||
CACNA1H | ENST00000711448.1 | n.498C>T | non_coding_transcript_exon_variant | Exon 4 of 36 | ENSP00000518760.1 | |||||
CACNA1H | ENST00000711449.1 | n.498C>T | non_coding_transcript_exon_variant | Exon 4 of 35 | ENSP00000518761.1 | |||||
CACNA1H | ENST00000711451.1 | n.498C>T | non_coding_transcript_exon_variant | Exon 4 of 36 | ENSP00000518763.1 | |||||
CACNA1H | ENST00000711452.1 | n.498C>T | non_coding_transcript_exon_variant | Exon 4 of 36 | ENSP00000518764.1 | |||||
CACNA1H | ENST00000711453.1 | n.498C>T | non_coding_transcript_exon_variant | Exon 4 of 36 | ENSP00000518765.1 | |||||
CACNA1H | ENST00000711484.1 | n.498C>T | non_coding_transcript_exon_variant | Exon 4 of 35 | ENSP00000518773.1 | |||||
CACNA1H | ENST00000711486.1 | n.498C>T | non_coding_transcript_exon_variant | Exon 4 of 37 | ENSP00000518775.1 | |||||
CACNA1H | ENST00000711487.1 | n.498C>T | non_coding_transcript_exon_variant | Exon 4 of 36 | ENSP00000518776.1 | |||||
CACNA1H | ENST00000711488.1 | n.498C>T | non_coding_transcript_exon_variant | Exon 4 of 35 | ENSP00000518777.1 |
Frequencies
GnomAD3 genomes AF: 0.00480 AC: 730AN: 152116Hom.: 10 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
730
AN:
152116
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00613 AC: 1423AN: 232222 AF XY: 0.00597 show subpopulations
GnomAD2 exomes
AF:
AC:
1423
AN:
232222
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00230 AC: 3347AN: 1452142Hom.: 40 Cov.: 34 AF XY: 0.00226 AC XY: 1631AN XY: 721216 show subpopulations
GnomAD4 exome
AF:
AC:
3347
AN:
1452142
Hom.:
Cov.:
34
AF XY:
AC XY:
1631
AN XY:
721216
show subpopulations
African (AFR)
AF:
AC:
2
AN:
33336
American (AMR)
AF:
AC:
3
AN:
43450
Ashkenazi Jewish (ASJ)
AF:
AC:
190
AN:
25928
East Asian (EAS)
AF:
AC:
826
AN:
39288
South Asian (SAS)
AF:
AC:
114
AN:
83992
European-Finnish (FIN)
AF:
AC:
1690
AN:
52646
Middle Eastern (MID)
AF:
AC:
1
AN:
5710
European-Non Finnish (NFE)
AF:
AC:
303
AN:
1107738
Other (OTH)
AF:
AC:
218
AN:
60054
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
193
387
580
774
967
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00479 AC: 729AN: 152234Hom.: 10 Cov.: 33 AF XY: 0.00683 AC XY: 508AN XY: 74428 show subpopulations
GnomAD4 genome
AF:
AC:
729
AN:
152234
Hom.:
Cov.:
33
AF XY:
AC XY:
508
AN XY:
74428
show subpopulations
African (AFR)
AF:
AC:
6
AN:
41534
American (AMR)
AF:
AC:
2
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
20
AN:
3472
East Asian (EAS)
AF:
AC:
160
AN:
5172
South Asian (SAS)
AF:
AC:
15
AN:
4826
European-Finnish (FIN)
AF:
AC:
456
AN:
10616
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
63
AN:
67996
Other (OTH)
AF:
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
33
65
98
130
163
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
59
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.